Jump to the main content block
Your browser does not support JavaScript functionality. If the webpage function cannot be used properly, please enable the browser's JavaScript status
:::
Site Map
Home
College of Medicine
NCKU
中文
Burger Button
About us
Introduction
The Objective
Teaching Course
Floor Plan
Transportation
Logo
HEEACT Certificate of Recognition
Members
Teacher
Chair Professor
Technologists
Admissions
Admissions
Admissions for International Students
Course Requirements for Graduation
Research
Research
Video
Short Film
ONE DAY in NCKU
Regulations and Application Forms
Rule and Regulations
Application Forms
Know Our Laboratories and Activities
30th Anniversary Celebration
Know Our Laboratories
Life Silhouette
:::
Information Category Menu
Information Category Menu
Announcement
News
Admissions
Awards & Honors
Latest Research
About us
Introduction
The Objective
Teaching Course
Floor Plan
Transportation
Logo
HEEACT Certificate of Recognition
Members
Teacher
Chair Professor
Technologists
Admissions
Admissions
Admissions for International Students
Course Requirements for Graduation
Research
Research
Video
Short Film
ONE DAY in NCKU
Regulations and Application Forms
Rule and Regulations
Application Forms
Know Our Laboratories and Activities
30th Anniversary Celebration
Know Our Laboratories
Life Silhouette
:::
Home
Announcement
Announcement
News
Admissions
Awards & Honors
Latest Research
Discovery of a novel miconazole analogue as a dual apo-IDO1 inhibitor and ABCB1 modulator for cancer immunotherapy and chemosensitizing
BIRC5 Promoter-Driven Nanodrugs Suppress BIRC5-Positive Cancers Independent of ABCB1 Status and IDO1 Expression
Congratulations to Professor Liu Yen-wen of our institute for winning the 2025 National Science Council Outstanding Research Award
BDNF Val66Met protects oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer
Admission Prospectus for International Students 2026 Fall/ 2027 Spring
Login Success
Close (Esc)
Share
Toggle fullscreen
Zoom in/out
Previous (arrow left)
Next (arrow right)
